Trends in Prices of Popular Brand-Name Prescription Drugs in the United States.

ABSTRACT:

Importance

High and continually increasing pharmaceutical drug spending is a major health and health policy concern in the United States.

Objective

To demonstrate trends in prices among popular brand-name prescription drugs.

Design, setting, and participants

This economic evaluation of drug prices focuses on 49 top-selling brand-name medications in the United States. Pharmacy claims data from January 1, 2012, through December 31, 2017, were obtained from Blue Cross Blue Shield Axis, a database that includes data from more than 35 million individuals with private pharmaceutical insurance. Drugs that exceeded $500 million in US sales or $1 billion in worldwide sales were examined.

Main outcomes and measures

The median sum of out-of-pocket and insurance costs paid

SUBMITTER: Wineinger NE 

PROVIDER: S-EPMC6547085 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature